Literature DB >> 28794383

Hypertrophic Pachymeningitis Accompanying Scleritis.

Kosuke Oka1, Kazuki Ocho1, Masaya Iwamuro1, Fumio Otsuka1.   

Abstract

Entities:  

Keywords:  headache; hypertrophic pachymeningitis; scleritis

Year:  2017        PMID: 28794383      PMCID: PMC5635322          DOI: 10.2169/internalmedicine.8850-17

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
An elderly woman undergoing treatment for organizing pneumonia and Graves's disease complained of severe headache after a reduction of her oral prednisolone dose (5 mg/day to 2.5 mg/day). Although her headache resolved spontaneously, it recurred with severe ophthalmalgia and she showed bloodshot eyes. Enhanced MRI revealed a thickened dura mater with a contrast effect (Picture A and C: coronal, Picture B: sagittal), leading to a diagnosis of hypertrophic pachymeningitis. The patient was positive for myeloperoxidase anti-neutrophil cytoplasmic antibodies and her immunoglobulin G4 level was elevated. Moderate scleritis was ophthalmologically evident (Picture D). Intravenous methylprednisolone (500 mg for 3 days) followed by oral prednisolone (30 mg/day) improved her headache, eye pain, and MRI findings.
Picture
The typical symptoms of hypertrophic pachymeningitis include headache with or without intracranial neurologic manifestations such as cranial neuropathy and cerebellar dysfunction (1). Despite the rarity, this disease combination should be kept in mind when we encounter patients with headache and eye pain (2).

The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  A case of hypertrophic cranial pachymeningitis presenting with scleritis in a patient with undifferentiated connective tissue disease.

Authors:  Ji-Hyeon Kim; Young-Bin Joo; Jeana Kim; Jun-Ki Min
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

Review 2.  Idiopathic hypertrophic cranial pachymeningitis. Report of three cases.

Authors:  A N Mamelak; W M Kelly; R L Davis; M L Rosenblum
Journal:  J Neurosurg       Date:  1993-08       Impact factor: 5.115

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.